EDIT:NASDAQ
Editas Medicine Inc
2,51 US$
0,00%
(0,00) 1D
22 ოქტ, 11:32:33 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,47 US$
High
2,58 US$
Low
2,45 US$
Mkt. cap
386,25 მლნ.
Avg. vol.
2,97 მლნ.
Volume
239,87 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
Open
2,47 US$
High
2,58 US$
Low
2,45 US$
Mkt. cap
386,25 მლნ.
Avg. vol.
2,97 მლნ.
Volume
239,87 ათ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
News stories
From web sources and news partners
StreetInsider
·
22 წუთის წინ
Click Holdings Limited (NASDAQ: CLIK) Reports Record Full-Year Results: Revenue, Gross Profit and Net Income Hit New Highs; Every Segment Delivers Record Revenue
ACROFAN USA
·
22 წუთის წინ
Xona Raises $250 Million as Part of Mission to Upgrade GPS: NYSE Content Update
MarketWatch
·
24 წუთის წინ
Investors’ recent money moves show a preference for quality over momentum within the S&P 500
Yahoo Finance
·
1 საათის წინ
Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc